Enhancing the Way Epilepsy is Managed by Engaging Community Pharmacists

The University of Washington’s School of Pharmacy announced on Thursday, Sept. 12, a collaboration with global biopharmaceutical company UCB to improve access to care for people living with epilepsy. This interdisciplinary project will explore ways in which community pharmacists can better support people living with this neurological disorder.

The roughly 3.4 million people nationally and 75,000 people in Washington state who live with epilepsy often get fragmented and uncoordinated healthcare and community services.

NewsBeat: Common Malaria Meds Pose No Undue Risk in Early Pregnancy

Global team finds that artemesinin therapies are as safe as quinine for women in first trimester

By Sarah C.B. Guthrie 

Artemisinin combination therapies (ACTs), medications widely used against malaria, are safe to administer to women in their first trimester of pregnancy, according to research published today. ACTs had previously been recommended at that stage of pregnancy only in life-saving circumstances. 

HS Newsbeat: Little-known Disease has Major Economic Impact

By Ashlie Chandler

Healthcare system spending on patients in the United States with giant cell arteritis is $16,400 more in the first year after diagnosis compared to similar patients without the disease. This finding comes from a new study from the University of Washington School of Public Health. The little-known, chronic disease of the blood vessels affects 230,000 Americans.